Elekta Unity
Device Linac Solutions (Mr-Linac)
PDI 05060191071598
General payments
$244,953
Research payments
$1,083,088
Through program year 2025, $244,953 in general payments and $1,083,088 in research payments were reported against Elekta Unity (Linac Solutions (Mr-Linac)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $30,086 | 99 |
| 2025 | Research | $245,286 | 4 |
| 2024 | General | $2,916 | 31 |
| 2023 | General | $71,059 | 102 |
| 2023 | Research | $837,802 | 23 |
| 2022 | General | $62,738 | 123 |
| 2021 | General | $78,152 | 91 |
Breakdown
The top 5 of 51 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
446 general · 27 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.